جست‌وجوی استاد و پژوهشگر

• Transplantation Immunology
• Immunological Tolerance
• Humoral Immunity
• +۷ مورد دیگر

Professor Anita Chong is a distinguished immunologist at the University of Chicago's Pritzker School of Medicine, Department of Surgery-Transplant, where she leads groundbreaking research in transplantation immunology and tolerance mechanisms. Her laboratory has established herself as a leading authority in understanding the complex interplay between the immune system and organ transplantation. Dr. Chong's educational background includes a BS (Hons) from the University of Malaya, Malaysia, a PhD from Australian National University, Australia, and postdoctoral training at Tufts University, Boston, MA, followed by research associate work at the University of Arizona, Tucson, AZ. Her research program focuses on immunological tolerance and humoral immunity following allogeneic transplantation, with particular emphasis on understanding how infections prevent the induction of transplantation tolerance or destabilize established tolerance. Dr. Chong has developed innovative approaches to track defined populations of endogenous allospecific T cells (including CD4+ effectors, CD4+ Tregs, and CD8 effectors) and B cells, examining their behavior under conditions of rejection, memory/sensitization, and tolerance. She actively investigates memory alloreactive B cells in transplantation settings and has expanded her research into vaccination strategies to prevent infections as a means of stabilizing tolerance. Analysis of Dr. Chong's recent publications reveals a strong focus on cellular mechanisms of transplant tolerance and rejection, with particular emphasis on B cell biology, T regulatory cells, and the impact of infections on transplant outcomes. Her work increasingly incorporates multi-omics approaches and examines sex and gender differences in transplant outcomes, reflecting evolving trends in precision medicine within transplantation. Dr. Chong serves as Principal Investigator on multiple significant NIH-funded research projects, including R01AI182097 (Mechanistic studies on pregnancy-induced humoral sensitization in organ transplantation), R01AI148705 (Intrarenal B cells in acute kidney allograft rejection), and R01AI142747 (Deconstructing B cell transplantation tolerance). She has also served as Co-Principal Investigator on numerous collaborative grants. Her laboratory maintains extensive collaborations with Dr. Marisa Alegre studying infections and transplantation tolerance, Dr. Roger Sciammas at UC Davis, clinical transplant faculty at the University of Chicago and Ohio State University, Dr. Chris Montgomery on vaccination research, and Dr. Joel Collier at Duke University developing nanoparticulate adjuvant-free vaccines. These collaborative efforts have positioned her laboratory at the forefront of translational transplantation research with significant implications for clinical practice.

• Neuroscience
• Metabolism
• Behavioral Neuroscience
• +۳ مورد دیگر

Dr. Paulius Viskaitis is a Researcher affiliated with the Rehabilitation Engineering Lab at ETH Zürich's Department of Health Sciences and Technology. His work focuses on the neurophysiological mechanisms underlying metabolic regulation, motor behavior, and neurological disorders. Key research areas include orexin neuron dynamics, hypothalamic circuitry, and their roles in movement, energy homeostasis, and epilepsy mitigation. His studies integrate experimental neuroscience with engineering approaches, exploring how neural networks encode metabolic states and behavioral outputs. Notable contributions include identifying orexin neurons' roles in blood glucose tracking and seizure suppression. Current research emphasizes translational applications in rehabilitation engineering and neurotherapeutic strategies. Dr. Viskaitis collaborates across disciplines, leveraging mouse models to investigate neural circuits governing feeding, locomotion, and decision-making. His findings bridge basic neuroscience with clinical applications, particularly in metabolic and motor disorders.

Christopher S. Sullivanمشاهده پروفایل

استاد

• Virology
• Non-coding RNA Biology
• RNA Interference
• +۵ مورد دیگر

Christopher S. Sullivan is a Professor in the Department of Molecular Biosciences within the College of Natural Sciences at the University of Texas at Austin. He directs an active research laboratory focused on viral non-coding RNA biology and host-pathogen interactions, with continuous funding evidenced by publications spanning 2005-2025. His work bridges molecular virology, immunology, and RNA biology through investigations of tumor viruses and host defense mechanisms. Research interests center on the role of non-coding RNAs in viral infection and host defense pathways, with particular emphasis on viral microRNAs , RNA interference mechanisms , and host-pathogen coevolution . His lab studies diverse virus families including Polyomaviridae, Herpesviridae, Retroviridae, and avipoxviruses, with key discoveries regarding viral miRNA functions in tumorigenesis and immune evasion. Research approaches integrate molecular virology, next-generation sequencing, and computational analysis to dissect RNA-based regulatory networks. Publications reveal consistent focus on viral non-coding RNA functions, particularly how viruses exploit host RNA machinery (notably DUSP11 phosphatase) to modulate immune responses. Recent work (2021-2025) expands into viral shedding dynamics, SARS-CoV-2 diagnostics, and circular RNA biology in polyomaviruses, demonstrating evolving yet cohesive research trajectory in RNA-virus interactions. Scientific contributions include: Pioneering identification of viral microRNAs across multiple virus families Discovery of DUSP11's critical role in RNA triphosphate regulation during infection Mechanistic insights into viral evasion of RNAi and innate immunity Development of novel RNA-based detection methods The Sullivan lab maintains active collaborations through the Center for Systems and Synthetic Biology, John Ring LaMontagne Center for Infectious Disease, and Interdisciplinary Life Sciences Graduate Programs. Lab culture emphasizes collective scientific inquiry with stated mission to 'increase understanding of pathogen-host interactions while enjoying the company of fellow lab members.' Current research directions include viral exploitation of RNA modification pathways and identification of novel host defense mechanisms using viruses as 'molecular divining rods.'

Andrew McArthurمشاهده پروفایل

استاد

• Bioinformatics
• Genomics
• Antimicrobial Resistance
• +۵ مورد دیگر

Andrew McArthur is a Professor in the Department of Biochemistry & Biomedical Sciences at McMaster University, where he leads the McArthur Laboratory. His research focuses on bioinformatics , genomics , and computational biology with a specialization in genomic surveillance of antimicrobial resistance (AMR) . He spearheads the Comprehensive Antibiotic Resistance Database (CARD) and collaborates with the Canadian Anti-Infective Innovation Network (CAIN) , GenEpio Consortium , and IRIDA Platform for pathogen genomics. Education : PhD in Biochemistry (University of Victoria, 1996), Postdoctoral work at Marine Biological Laboratory (1998-1999) and National Museum of Natural History (1996-1998) His research spans antimicrobial resistance surveillance , machine learning applications , viral genomics (including SARS-CoV-2), and pathogen evolution . He has developed tools like CARD and IRIDA to standardize AMR data and enable rapid infectious disease analysis. Recent work includes machine learning models for predicting AMR, cloud-based pathogen detection , and resistome profiling in clinical and environmental contexts. He has mentored graduate students including Jalees Nasir (HSGSA Impact Award 2025), Dirk Hackenberger , Autumn Arnold , and Emily Bordeleau , as well as postdoctoral fellows like Sheridan Baker . His teaching includes courses in practical bioinformatics and biomedical consulting at McMaster University.

John M. Hendersonمشاهده پروفایل

استاد

• Cognitive Psychology
• Visual Cognition
• Scene Perception
• +۳ مورد دیگر

John M. Henderson is a Distinguished Professor at the University of California, Davis , affiliated with the Visual Cognition Lab . He holds additional roles at the Center for Mind and Brain , Center for Vision Science , Center for Neuroscience , and Plasticity and Memory Program . As an editor for Collabra: Psychology and associate editor for Journal of Experimental Psychology: General , he contributes to open science and cognitive research dissemination. Ph.D. in Cognitive Psychology, University of Massachusetts, Amherst (1988) M.S. in Cognitive Psychology, University of Massachusetts, Amherst (1986) B.S. in Psychology, University of Massachusetts, Amherst (1983) Professor Henderson’s research investigates how visual information is acquired, recognized, and integrated into cognitive systems to guide behavior. His work combines scene perception , reading processes , and visual memory using eye tracking , fMRI , brain stimulation , and computational modeling . Recent studies explore semantic guidance of attention in natural scenes, neural correlates of fixation duration, and developmental attentional patterns. His 15 most recent publications (2023-2025) reflect a focus on semantic processing in visual cognition , scene perception , and computational modeling of attention . Topics include meaning-based attentional guidance, deep learning applications in scene analysis, and neural mechanisms of memory-guided eye movements. Collaborations span cognitive neuroscience, developmental psychology, and AI-driven scene understanding. Scientific honors include: Google Scholar Classics recognition (2017) for groundbreaking 2006 paper Fellow of the Association for Psychological Science, American Psychological Association, and Psychonomic Society Grants from the National Eye Institute and National Institute on Aging support his work on visual cognition and aging. His lab trains students in cognitive methods and interdisciplinary research, bridging psychology, neuroscience, and computational modeling.

Andrew Godwinمشاهده پروفایل

استاد

• Molecular Oncology
• Precision Medicine
• Biomarker Discovery
• +۳ مورد دیگر

Andrew Godwin is a Professor at the University of Kansas Medical Center , where he serves as the Chancellor’s Distinguished Chair in Biomedical Sciences and Director of Molecular Oncology in the Department of Pathology and Laboratory Medicine. He is also the Deputy Director of the NCI-designated University of Kansas Cancer Center and the Founding Director of the Kansas Institute for Precision Medicine and Biospecimen Shared Resource . Dr. Godwin is a leader in translational research and precision medicine , with a focus on molecular oncology , biomarker discovery , and genomic diagnostics . His work bridges basic and clinical science to improve cancer patient care, particularly in ovarian cancer , Ewing sarcoma , and breast cancer . He has contributed over 230 ovarian cancer-related publications and pioneered studies linking the PI3K/AKT pathway to cancer treatment targets. His research program encompasses liquid biopsies using extracellular vesicles , molecular therapeutics , companion diagnostics , and clinical trial validation . He leads the Biomarker Discovery Laboratory and has secured over $250M in extramural funding , including a $11.4M NIH grant for precision medicine initiatives. His team has developed CELLSEARCH® , the first FDA-cleared test for circulating tumor cells. Notable awards include the Dolph C. Simons, Sr. Higuchi Award (2020), Outstanding Mentorship in Pathology Award (2024), and multiple mentoring accolades from KU. He has mentored over 150 trainees across career stages and leads a multidisciplinary lab with expertise in genomics , proteomics , and bioengineering . Academic Roles: Chancellor’s Distinguished Chair in Biomedical Sciences Director, Molecular Oncology, Pathology and Laboratory Medicine Deputy Director, KU Cancer Center Founding Director, Kansas Institute for Precision Medicine Adjunct Professor, Bioengineering Program, University of Kansas Scientific Awards: KUMC Achievement Award for mentoring postdocs (2014) Chancellor’s Club Award for Research (2018) Dolph C. Simons, Sr. Higuchi Award (2020) KU Excellence in Mentoring Award (2021) Outstanding Mentorship in Pathology (2024) Key Research Themes: Extracellular vesicles as liquid biopsy tools Molecular mechanisms of sarcoma and breast cancer Genomic diagnostics and precision oncology Clinical trial biomarker validation Biospecimen repository leadership

Jingsong Zhouمشاهده پروفایل

استاد

• Neuromuscular Diseases
• Striated Muscle Physiology
• Calcium Signaling
• +۴ مورد دیگر

Dr. Jingsong Zhou is a Professor of Kinesiology and Associate Director of the Bone-Muscle Research Center at The University of Texas at Arlington. Her research focuses on neuromuscular diseases, particularly Amyotrophic Lateral Sclerosis (ALS), with expertise in striated muscle physiology, calcium signaling, and mitochondrial dysfunction. She leads the Neuromuscular Diseases Lab, which develops genetic mouse models and molecular probes to study ALS mechanisms. Dr. Zhou’s work has been supported by NIH, MDA, DOD, and the ALS Association. She serves on the NIH SMEP study section and has over 20 years of academic experience, including postdoctoral training at Vanderbilt University College of Medicine and a PhD from Rush University School of Medicine. Education: Postdoctoral Fellow in Pharmacology, Vanderbilt University College of Medicine (2001) PhD in Molecular Biophysics and Physiology, Rush University School of Medicine (1997) Diploma in Medicine, Hunan Medical University (Xiangya Medical School) (1986) Research Interests: Mechanisms of calcium signaling and mitochondrial dysfunction in ALS Role of sarcolemma repair and autophagy in neuromuscular disease progression Development of therapeutic strategies targeting mitochondrial health and membrane integrity Grants and Funding: NIH grants focused on ALS pathogenesis and muscle-bone interactions Support from MDA, DOD, and ALS Association for translational research projects Labs and Teams: Director of the Neuromuscular Diseases Lab at UT Arlington Collaborations in developing mouse models and molecular tools for ALS research

Maureen A. Kaneمشاهده پروفایل

استاد

• Mass Spectrometry
• Retinoid Metabolism
• Biomarker Development
• +۳ مورد دیگر

Maureen A. Kane, PhD, is a Professor and Executive Director of the Mass Spectrometry Center at the University of Maryland School of Pharmacy, Department of Pharmaceutical Sciences. She holds leadership roles in analytical chemistry, biomarker discovery, and translational research. Dr. Kane’s research focuses on mass spectrometry-based methodologies, retinoid metabolism, and radiation injury biomarkers. Education & Experience: BS in Chemistry, Canisius College (1995) PhD in Chemistry, University at Buffalo (2002) Postdoctoral Fellow, University of California, Berkeley (2003–2009) Assistant Professor (2009–2015), Associate Professor (2015–2022), and Professor (2022–present), University of Maryland School of Pharmacy Executive Director, Mass Spectrometry Center (2015–present) Research Interests: Dr. Kane’s work integrates advanced mass spectrometry techniques with biochemical studies to address disease mechanisms. Key areas include retinoid signaling in development and reproduction, radiation injury biomarkers, and pharmaceutical analysis. Her lab develops novel methods for metabolomics, lipidomics, and imaging mass spectrometry. Biomarker Research Highlights: Her team identifies biomarkers for radiation exposure outcomes, prenatal alcohol exposure, and traumatic brain injury. Collaborations with MCART (Medical Countermeasures Against Radiological Threat) consortium advance medical countermeasure development. Awards: Champions of Excellence Award (2018) Teacher of the Year (2011–2012) Waters Center of Innovation (2013–present) Grants & Advising: Dr. Kane leads NIH-funded projects on retinoid metabolism and radiation biomarkers. She mentors over 20 graduate students and postdocs, with many alumni in academic and industry roles. Lab & Facilities: The Mass Spectrometry Center, directed by Dr. Kane, provides cutting-edge instrumentation for proteomics, lipidomics, and MALDI-MSI. It supports collaborative research across disciplines.

David S. Marchمشاهده پروفایل

استادیار

• Social Psychology
• Implicit Cognition
• Threat Perception
• +۳ مورد دیگر

David S. March is an Assistant Professor in the Department of Psychology at Florida State University's College of Arts and Sciences. His research focuses on implicit cognition and threat processing, particularly how subconscious threat evaluation influences attitudes, prejudice, and behavioral responses. He actively recruits graduate students for Fall 2026 and oversees the March Research Laboratory. His research integrates social cognition, cognitive neuroscience, and behavioral psychology to challenge dual process models by introducing a speed-strength distinction between threatening and nonthreatening stimuli. Key areas include automacity of threat responses, racial bias mechanisms, and methodological advancements in mouse-tracking analysis. Dr. March's publications examine threat perception in contexts ranging from snake fear to police bias, contributing to understanding how implicit threat evaluations shape social behaviors and policy compliance. His work bridges evolutionary psychology with modern social issues like racial prejudice and pandemic health behaviors. Scientific Awards: Student Publication Prize by the Society for Personality and Social Psychology (2017)

• Neuroscience
• Olfactory System
• Central Nervous System Development
• +۴ مورد دیگر

Charles A. Greer is Professor of Neurosurgery and Neuroscience at Yale School of Medicine, where he serves as Co-Vice Chair of Research for Neurosurgery and Director of the Yale Interdepartmental Neuroscience Graduate Program. He maintains joint appointments in both the Department of Neurosurgery and Department of Neuroscience, with additional affiliations through the Wu Tsai Institute, Yale Combined Program in the Biological and Biomedical Sciences, and Yale Stem Cell Center. Dr. Greer's research focuses on understanding the fundamental mechanisms that establish orderly topographic maps within the central nervous system during development and regeneration. His laboratory primarily investigates the complex olfactory system, studying how axons sort into functional subsets and target specific regions in the olfactory bulb. His work has significant implications for understanding neural regeneration following injury or disease, particularly through his research on ensheathing cells that support axon growth and can promote remyelination in damaged spinal cord tissue. His research spans multiple disciplines including neuroanatomy, developmental neuroscience, and neural regeneration, with particular emphasis on the molecular and cellular mechanisms of axon targeting, glial cell function, and neural circuit formation. Dr. Greer has established extensive collaborations across Yale departments including Neurology, Neurobiology, Anesthesiology, and Ophthalmology, as well as with institutions including Columbia University, Emory University, The Rockefeller University, University of Maryland, and University of Colorado. Dr. Greer has received numerous prestigious awards including the Max Mozell Award for Outstanding Achievements in the Chemical Senses, the R.H. Wright Award for Outstanding Research in Olfaction, and recognition as Distinguished Professor from Universite Pierre et Marie Curie in Paris. He has served as President of the Association for Chemoreception Sciences and as a member of NIH study sections and the Advisory Council for the National Institute on Deafness and Other Communication Disorders. As an educator, Dr. Greer has directed the Yale Interdepartmental Neuroscience Graduate Program and mentored numerous students and postdoctoral fellows. He serves as Associate Editor for The Journal of Comparative Neurology and Journal of Neuroscience, and sits on the editorial boards of several other neuroscience journals. His extensive publication record demonstrates sustained contributions to understanding the organization and development of neural systems, particularly the olfactory pathway.

Cornelius Faberمشاهده پروفایل

استاد

• MRI cell tracking
• infection imaging
• MR methodology
• +۶ مورد دیگر

Cornelius Faber is a University Professor in the Department of Radiology at the University of Münster, Germany, where he leads the Experimental Nuclear Magnetic Resonance research group. His work focuses on developing and implementing novel MRI techniques that extend the boundaries of magnetic resonance imaging in terms of spatial and temporal resolution, sensitivity, and specificity for physiological, structural, and molecular changes. He actively participates in the "Cells in Motion" interdisciplinary research initiative at the university. Professor Faber's research spans multiple critical areas in medical imaging and biomedical science. His primary expertise lies in MRI cell tracking , enabling visualization of cellular dynamics in vivo. He has made significant contributions to infection imaging , developing methods to detect and characterize microbial infections using MRI. His work on MR methodology development has advanced quantitative imaging techniques, while his research on multimodal integration in MR and MRI contrast mechanisms has provided deeper insights into molecular and cellular processes. His research bridges physics, engineering, and biomedical applications, with particular relevance to inflammation, cancer, neurological disorders, and cardiovascular disease. Analysis of Professor Faber's extensive publication record reveals a clear evolution from fundamental MRI technique development toward increasingly sophisticated applications in disease models. His recent work demonstrates a strong trend toward multimodal imaging approaches that combine MRI with complementary techniques such as mass spectrometry, optical imaging, and PET. This integration creates comprehensive diagnostic platforms that provide both anatomical and molecular information. A notable pattern is the focus on cellular dynamics, particularly immune cell behavior in inflammatory conditions and tumor microenvironments, with applications spanning neuroscience, oncology, and cardiology. Professor Faber leads a multidisciplinary research team of approximately 15 members, including scientists, doctoral students, technicians, and medical students. His laboratory is deeply integrated with the University of Münster's research infrastructure, particularly the Multiscale Imaging Centre. The group's work contributes significantly to advancing preclinical MRI methodologies while maintaining strong clinical relevance, with numerous publications in high-impact journals across medical imaging, neuroscience, and biomedical engineering disciplines.

Alvaro Köhn-Luqueمشاهده پروفایل

دانشیار

• Mathematical Oncology
• Computational Biology
• Biostatistics
• +۷ مورد دیگر

Alvaro Köhn-Luque is an Associate Professor at the Oslo Center for Biostatistics and Epidemiology, University of Oslo, and Group Leader at the Department of Medical Genetics, Oslo University Hospital. His work bridges mathematical modeling with clinical applications, particularly in cancer research. His academic background includes a PhD in Mathematical and Computational Biology from Complutense University of Madrid (2012), preceded by multiple Master's degrees in Mathematics and Physics from Spanish universities. Dr. Köhn-Luque's research focuses on mathematical oncology , developing computational models to understand cancer dynamics and improve treatment strategies. His work spans multiscale modeling of tumor growth, personalized cancer medicine through computer simulations, and biomarker discovery using machine learning approaches. He has made significant contributions to modeling breast cancer progression and treatment response, particularly in the context of endocrine therapy and CDK4/6 inhibition. His recent publications demonstrate a strong trend toward integrating mechanistic learning approaches that combine mathematical models with machine learning techniques. This hybrid methodology allows for more accurate prediction of treatment outcomes while maintaining biological interpretability. His work frequently involves collaboration with clinical researchers to ensure models are grounded in real patient data and have direct translational potential. Computational modeling of tumor heterogeneity and drug response Development of methods for phenotypic deconvolution in cancer cell populations Integration of multi-omics data for personalized treatment prediction Application of birth-death processes to model tumor evolution Creation of user-friendly computational tools for biomedical researchers Dr. Köhn-Luque has supervised multiple PhD students including Even M Myklebust, Salim Ghannoum, and Xiaoran Lai, and has secured funding for projects including RESCUE, BigInsight, and Integreat. His research demonstrates a consistent trajectory from theoretical mathematical biology toward increasingly clinically relevant applications in personalized cancer medicine.

• Medical Physics
• Radiation Therapy
• Medical Imaging
• +۷ مورد دیگر

Andrew Fielding is an Associate Professor in the School of Chemistry & Physics at Queensland University of Technology (QUT), Faculty of Science. His research and teaching focus on medical physics, particularly in radiation therapy, medical imaging, and Monte Carlo dosimetry techniques. He is the Course Coordinator for the Graduate Diploma and Master of Applied Science in Medical Physics programs at QUT. He holds a PhD in Physics from the University of Portsmouth and a B.Sc. (Hons) from the University of Surrey. He completed postdoctoral research at the Institute of Cancer Research / Royal Marsden Hospital and the University of Liverpool before joining QUT in 2004. His academic progression includes Lecturer (2004–2008), Senior Lecturer (2008–2022), and Associate Professor (2023–present). His research interests lie in medical imaging, radiation therapy, image-guided radiotherapy, Monte Carlo techniques for dosimetry, and radiation oncology physics. He emphasizes translating research into clinical practice to improve cancer care. His recent publications reflect a strong focus on Monte Carlo simulations, small-field dosimetry, preclinical irradiation, and the integration of AI and simulation in radiotherapy education and treatment verification. His scientific achievements are recognized through professional memberships including Fellow of the Institute of Physics (FInstP), Chartered Physicist (CPhys), and Member of the Australasian College of Physical Scientists and Engineers in Medicine (MACPSEM). Fellow of the Institute of Physics (FInstP) Chartered Physicist (CPhys) Member of the Australasian College of Physical Scientists and Engineers in Medicine (MACPSEM) Andrew Fielding actively supervises PhD and research master’s students in areas such as Monte Carlo dosimetry, tumor motion tracking, and radiotherapy optimization. He has secured competitive research grants, including Australian Competitive Grants for projects on tumor motion monitoring and in-vivo dosimetry verification. His teaching philosophy emphasizes authentic, clinically aligned learning using simulation, virtual reality, and real-world applications. He leads or teaches several core medical physics units, including Radiation Physics, Radiotherapy, Medical Imaging Science, and Research Methodology. He is involved in developing and evaluating innovative tools such as 3D volumetric outlining systems and immersive simulation environments for radiotherapy training. His work bridges physics, clinical application, and education, contributing significantly to the advancement of medical physics both in research and pedagogy.

Pratip K. Bhattacharyaمشاهده پروفایل

دانشیار

• Magnetic Resonance Imaging (MRI)
• Hyperpolarized MRI
• Metabolic Imaging
• +۹ مورد دیگر

Pratip K. Bhattacharya, Ph.D. , is an Associate Professor in the Department of Cancer Systems Imaging and the Department of Imaging Physics at The University of Texas MD Anderson Cancer Center, with a joint appointment in the Graduate School of Biomedical Sciences at The University of Texas Health Science Center. He is a principal investigator leading the Bhattacharya Laboratory, dedicated to advancing magnetic resonance imaging (MRI) through hyperpolarization techniques for applications in cancer and cardiovascular diseases. His research focuses on developing real-time metabolic and molecular imaging methods using hyperpolarized 13 C and 15 N-labeled compounds and silicon nanoparticles. These innovative probes significantly enhance MRI sensitivity, enabling non-invasive assessment of tissue metabolism and targeted imaging. His lab's work spans three primary areas: real-time metabolic MR imaging, targeted molecular MR imaging with functionalized silicon nanoparticles, and high-resolution MR metabolomics. These efforts are aimed at improving disease diagnosis and therapy monitoring. Analysis of his recent publications reveals a strong and consistent focus on hyperpolarized MRI, particularly using silicon particles and metabolic tracers like succinate, to visualize cancer metabolism and cardiovascular conditions in vivo. His research integrates physics, chemistry, and biomedical engineering to create novel imaging tools with direct clinical translational potential. PHIP Hyperpolarization Dynamic Nuclear Polarization (DNP) Hyperpolarized Silicon Nanoparticles Real-Time Metabolic Imaging Cancer and Cardiovascular Imaging Theranostic Applications Dr. Bhattacharya actively mentors graduate students and postdoctoral fellows, including Saleh Ramezani, Jose Enriquez, Dontrey Bourgeois, and Kang-Lin Hsieh. He collaborates closely with physician-scientists, radiologists, and oncologists to ensure his imaging science innovations address critical clinical needs. His laboratory is supported by grant funding, facilitating the development of cutting-edge imaging technologies. The Bhattacharya Laboratory is a key component of the Division of Diagnostic Imaging at MD Anderson, fostering a collaborative environment for interdisciplinary research. The lab focuses on translating fundamental discoveries in hyperpolarization physics into practical tools for improving cancer care.

• Stem Cell Research
• Orthopedics
• Sports Medicine
• +۵ مورد دیگر

Dr. Sohrab Khatab is a Researcher in the Department of Orthopedics and Sports Medicine at Erasmus MC, a leading medical center affiliated with Erasmus University Rotterdam. His work focuses on innovative treatments for joint disorders, particularly using stem cell therapies and regenerative medicine approaches. Dr. Khatab's research spans multiple disciplines including orthopedics, veterinary science, and regenerative medicine. His primary interests include stem cell research, arthritis treatment, intra-articular therapies, and osteoarthritis management. His work utilizes various animal models including equine, murine, and in vitro systems to develop novel treatments for joint inflammation and cartilage damage. Analysis of Dr. Khatab's publications reveals a consistent focus on regenerative approaches for joint disorders. His research demonstrates expertise in stem cell secretome applications, platelet-rich plasma therapies, and biomaterial encapsulation techniques. The work shows progression from basic in vitro studies to more complex animal models, indicating translational research aimed at clinical applications in orthopedics and sports medicine. Dr. Khatab has collaborated extensively with researchers at Erasmus MC, particularly with G. van Osch, N. Kops, K. Bos, and J. Verhaar. His work has generated significant academic interest with multiple publications accumulating substantial citations in the field of orthopedic regenerative medicine. Dr. Khatab's research is conducted within the Orthopedics and Sports Medicine department at Erasmus MC, which appears to have strong capabilities in regenerative medicine, stem cell research, and translational orthopedics. His work with both equine and murine models suggests access to comprehensive laboratory facilities for preclinical testing of novel orthopedic treatments.